214 related articles for article (PubMed ID: 33978330)
21. Co-Infection with Common Respiratory Pathogens and SARS-CoV-2 in Patients with COVID-19 Pneumonia and Laboratory Biochemistry Findings: A Retrospective Cross-Sectional Study of 78 Patients from a Single Center in China.
Tang ML; Li YQ; Chen X; Lin H; Jiang ZC; Gu DL; Chen X; Tang CX; Xie ZQ
Med Sci Monit; 2021 Jan; 27():e929783. PubMed ID: 33388738
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of biological markers in the early prediction of corona virus disease-2019 severity.
Bennouar S; Bachir Cherif A; Kessira A; Hamel H; Boudahdir A; Bouamra A; Bennouar D; Abdi S
Scand J Clin Lab Invest; 2020 Dec; 80(8):611-618. PubMed ID: 32945705
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
[TBL] [Abstract][Full Text] [Related]
24. Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.
Cui N; Yan R; Qin C; Zhao J
Front Cell Infect Microbiol; 2020; 10():595333. PubMed ID: 33365277
[TBL] [Abstract][Full Text] [Related]
25. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
Gil-Rodrigo A; Miró Ò; Piñera P; Burillo-Putze G; Jiménez S; Martín A; Martín-Sánchez FJ; Jacob J; Guardiola JM; García-Lamberechts EJ; Espinosa B; Martín Mojarro E; González Tejera M; Serrano L; Agüera C; Soy E; Llauger L; Juan MÁ; Palau A; Del Arco C; Rodríguez Miranda B; Maza Vera MT; Martín Quirós A; Tejada de Los Santos L; Ruiz de Lobera N; Iglesias Vela M; Torres Garate R; Alquézar-Arbé A; González Del Castillo J; Llorens P;
Emergencias; 2020 Ago; 32(4):233-241. PubMed ID: 32692000
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
Rodriguez-Gonzalez CG; Chamorro-de-Vega E; Valerio M; Amor-Garcia MA; Tejerina F; Sancho-Gonzalez M; Narrillos-Moraza A; Gimenez-Manzorro A; Manrique-Rodriguez S; Machado M; Olmedo M; Escudero-Vilaplana V; Villanueva-Bueno C; Torroba-Sanz B; Melgarejo-Ortuño A; Vicente-Valor J; Herranz A; Bouza E; Muñoz P; Sanjurjo M
Int J Antimicrob Agents; 2021 Feb; 57(2):106249. PubMed ID: 33259918
[TBL] [Abstract][Full Text] [Related]
27. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
[TBL] [Abstract][Full Text] [Related]
28. A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality.
Serin I; Sari ND; Dogu MH; Acikel SD; Babur G; Ulusoy A; Onar MI; Gokce EC; Altunok O; Yaylaci Mert F; Karakilic A; Baltik M; Gulesir B
J Infect Public Health; 2020 Nov; 13(11):1664-1670. PubMed ID: 33071210
[TBL] [Abstract][Full Text] [Related]
29. Cytokine storm in severe COVID-19 pneumonia.
Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
[TBL] [Abstract][Full Text] [Related]
30. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city.
Ares-Blanco S; Pérez Álvarez M; Gefaell Larrondo I; Muñoz C; Aguilar Ruiz V; Castelo Jurado M; Guisado-Clavero M
PLoS One; 2021; 16(9):e0257604. PubMed ID: 34551007
[TBL] [Abstract][Full Text] [Related]
32. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
[TBL] [Abstract][Full Text] [Related]
33. Clinical course of coronavirus disease-2019 in pregnancy.
Pereira A; Cruz-Melguizo S; Adrien M; Fuentes L; Marin E; Perez-Medina T
Acta Obstet Gynecol Scand; 2020 Jul; 99(7):839-847. PubMed ID: 32441332
[TBL] [Abstract][Full Text] [Related]
34. A safe protocol to identify low-risk patients with COVID-19 pneumonia for outpatient management.
Teigell Muñoz FJ; García-Guijarro E; García-Domingo P; Pérez-Nieto G; Roque Rojas F; García-Peña M; Nieto Gallo MA; Melero Bermejo JA; de Guzman García-Monge MT; Granizo JJ
Intern Emerg Med; 2021 Sep; 16(6):1663-1671. PubMed ID: 33620681
[TBL] [Abstract][Full Text] [Related]
35. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 infection in symptomatic pregnant women at the midpoint of the pandemic in Spain: a retrospective analysis.
Ortiz Molina E; Hernandez Pailos R; Pola Guillen M; Pascual Pedreno A; Rodriguez Rodriguez E; Hernandez Martinez A
Ginekol Pol; 2020; 91(12):755-763. PubMed ID: 33447995
[TBL] [Abstract][Full Text] [Related]
37. The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.
Cao H; Ruan L; Liu J; Liao W
J Med Virol; 2020 Oct; 92(10):2159-2164. PubMed ID: 32410245
[TBL] [Abstract][Full Text] [Related]
38. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
[TBL] [Abstract][Full Text] [Related]
39. An integrated emergency department/hospital at home model in mild COVID-19 pneumonia: feasibility and outcomes after discharge from the emergency department.
Llorens P; Moreno-Pérez O; Espinosa B; García T; Payá AB; Sola S; Molina F; Román F; Jiménez I; Guzman S; Gil-Rodrigo A; Peña-Pardo B; Merino E; Gil J; San-Inocencio D; Andrés M; Sánchez-Payá J
Intern Emerg Med; 2021 Sep; 16(6):1673-1682. PubMed ID: 33625661
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
